Andere Sprachen Co-Diagnostics, Inc.

Aktien

A2DU6V

US1897631057

CODX

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 10.05.2024			% 5 Tage	% 1. Jan.
1,11 ^USD	-9,76 %		-7,50 %	-16,54 %

09.05.	Transcript : Co-Diagnostics, Inc., Q1 2024 Earnings Call, May 09, 2024
12.04.	Co-Diagnostics, Inc. weiht neue Produktionsstätte in Utah mit Durchschneiden des Bandes ein	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results	09.05.
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast	25.04.
Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan	24.04.
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event	15.04.
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event	12.04.
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event	12.04.
Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions	04.04.
Co-Diagnostics, Inc. Appoints Executive Appointments	04.04.
Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address	21.03.
Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England	18.03.
Co-Diagnostics, Inc. Appoints Richard Abbott as President	15.03.
Tranche Update on Co-Diagnostics, Inc.'s Equity Buyback Plan announced on March 15, 2022.	14.03.
Co-Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14.03.
Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results	14.03.
Co-Diagnostics Gets Approval From India's Central Drugs Standard Control Organization For Manufacturing, Sale of Influenza Multiplex Test	07.03.
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test	07.03.
Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Webcast	29.02.
Southern District Of New York Declines To Dismiss Claims In Putative Class Action Against Medical Test Manufacturer	20.02.
Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for February 2024	01.02.
Co-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12	03.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Co-Diagnostics, Inc.

Aktien

A2DU6V

US1897631057

CODX

Andere Sprachen

Filter